Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Is AbbVie a Millionaire Maker?

Summary by The Motley Fool
Key PointsAbbVie is a pharmaceutical company with a focus on immunology, oncology, neuroscience, and aesthetics.The company's third-quarter earnings were down materially year over year, but it raised its full-year guidance.The stock's valuation is likely the biggest headwind to consider for long-term investors.10 stocks we like better than AbbVie › AbbVie (NYSE: ABBV) is an investment that is full of contradictions. It has a strong pharmaceutica…

1 Articles

The Motley FoolThe Motley Fool
Lean Left

Is AbbVie a Millionaire Maker?

Key PointsAbbVie is a pharmaceutical company with a focus on immunology, oncology, neuroscience, and aesthetics.The company's third-quarter earnings were down materially year over year, but it raised its full-year guidance.The stock's valuation is likely the biggest headwind to consider for long-term investors.10 stocks we like better than AbbVie › AbbVie (NYSE: ABBV) is an investment that is full of contradictions. It has a strong pharmaceutica…

·Alexandria, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Thursday, December 18, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock Markets icon

Stock Markets

North Chicago icon

North Chicago

Business & Markets icon

Business & Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal